MLN9708
CAS: 1201902-80-8
Ref. TM-T2016
| 5mg | 50.00 € | ||
| 10mg | 66.00 € | ||
| 25mg | 94.00 € | ||
| 50mg | 129.00 € | ||
| 100mg | 211.00 € | ||
| 200mg | 314.00 € | ||
| 500mg | 523.00 € | ||
| 1mL*10mM (DMSO) | 53.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Product Information
Name:
MLN9708
Synonyms:
- Ixazomib Citrate
- 4-Carboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-acetic acid
- Ixazomib
Description:
MLN2238 inhibits 20S proteasome's β5 site (Ki50=0.93 nM, IC50=3.4 nM), active form of Ixazomib Citrate in solutions/plasma.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
517.12
Formula:
C20H23BCl2N2O9
Purity:
98.24% - ≥95%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T2016 MLN9708
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
